The biotechnology and pharmaceutical industries are important sectors in the global economy, each with its own challenges and opportunities. FGMK can help you meet these challenges and capitalize on opportunities.
FGMK’s experience from working with companies in these key market sectors helps us advise them on their complex and unique financial, tax, operational and strategic needs. Our experienced professionals lead proactive teams providing practical business solutions. In addition, our industry-focused approach enables us to identify and respond to key performance and business issues without delay.
FGMK provides services to large and middle-market companies in the biotechnology and pharmaceuticals industry. We support them through:
STRATEGIC AND OPERATIONAL CONSULTING. We perform competitive and benchmark assessments, review operational and plant efficiencies, and identify, design and implement profit improvement plans that address today’s challenges.
ACQUISITION AND DIVESTITURE DUE DILIGENCE. We establish criteria for a competitive and strategic business combination transaction, allowing our clients to select and negotiate the best transaction.
TURNAROUND AND RESTRUCTURING SERVICES. We address the necessary changes in cash and liquidity management, debt finance or insolvency to help our clients emerge as viable, competitive participants in the industry.
FGMK can help you meet the challenges of the biotechnology and pharmaceutical industries and capitalize on opportunities.
